Results 111 to 120 of about 157,671 (305)

Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC

open access: yesCommunications Biology
Targeting the estrogen receptor alpha (ERα) pathway is validated in the clinic as an effective means to treat ER+ breast cancers. Here we present the development of a VHL-targeting and orally bioavailable proteolysis-targeting chimera (PROTAC) degrader ...
Thomas G. Hayhow   +35 more
doaj   +1 more source

KONSTRUKSI PEMBERITAAN EFEK SAMPING VAKSIN ASTRAZENECA PADA MEDIA ONLINE KOMPAS.COM DAN DETIK.COM

open access: yes, 2023
The spread of the corona virus is so fast almost to all corners of the world, including to Indonesia. Various kinds of policies carried out by the Indonesian government to ward off this virus, one of which is the vaccination policy.
Sholihul Abidin, Marbun, Angel Mei
core  

SARS-CoV-2 antibody status of AstraZeneca vaccinated persons.

open access: yes
SARS-CoV-2 antibody status of AstraZeneca vaccinated persons.
Issabella Asamoah (17941272)   +11 more
core   +1 more source

Preguntes sobre la represa de la vacuna amb Oxford/AstraZeneca [fullet]

open access: yes, 2021
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reanudación; Vacuna; Oxford / AstraZenecaCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Resumption; Vaccine; Oxford / AstraZenecaCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Represa; Vacuna; Oxford ...

core  

Geminal Difunctionalization of Ketones via C─S Bond Insertion of Photogenerated Donor–Donor Diazo Compounds

open access: yesAngewandte Chemie International Edition, EarlyView.
Geminal difunctionalization of readily available building blocks provides rapid access to molecular complexity. This work introduces a strategy for installing two distinct functional groups on a carbonyl carbon by transforming it into a donor–donor diazo compound, enabling both batch and flow applications with broad solvent compatibility.
Vincent George   +13 more
wiley   +1 more source

Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC

open access: yesnpj Precision Oncology
Immune checkpoint inhibitors targeting PD-1/PD-L1 are approved for metastatic non-small-cell lung cancer treatment. In clinical practice, the treatment choice depends on visual scoring of PD-L1, which is subjective and semi-quantitative. In this work, we
J. Lesniak   +17 more
doaj   +1 more source

Evaluating the Potential Infectious Risk Profile of Biologics in Chronic Rhinosinusitis With Nasal Polyposis

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Maxime Fieux   +2 more
wiley   +1 more source

The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer

open access: yesnpj Breast Cancer
Loss of PTEN expression, via homozygous or hemizygous deletion, is common in PIK3CA mutant ER + BC tumors. We assessed reduction of PTEN protein expression on AKT inhibitor capivasertib efficacy in PIK3CA altered tumors.
Valentina Cutano   +19 more
doaj   +1 more source

Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results From the Phase 2 Randomized Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE) and is partially driven by type I interferon signaling. Anifrolumab, an approved treatment for patients with SLE, has been investigated in a phase 2 trial in patients with LN receiving standard therapy (TULIP‐LN, ClinicalTrials.gov identifier ...
Andrea Fava   +8 more
wiley   +1 more source

Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a multiorgan disease with widespread immune dysregulation and significant unmet clinical need. Blood‐based gene expression studies have advanced our understanding of SLE pathogenesis but may overlook critical tissue‐specific mechanisms that drive disease heterogeneity and progression.
Michael A. Smith   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy